Status:
TERMINATED
An Intervention Study to Reduce the Use and Impact of Potentially Inappropriate Medications Among Older Adults
Lead Sponsor:
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Polypharmacy
Incontinence
Eligibility:
All Genders
65+ years
Phase:
PHASE4
Brief Summary
An educational intervention targeting community-dwelling older adults will lead to a reduction in potentially inappropriate prescriptions (e.g. benzodiazepines, oxybutynin). Cessation of potentially ...
Detailed Description
This study tests the effectiveness of a knowledge transfer tool for empowering patients to engage in collaborative discontinuation of potentially inappropriate medication with their pharmacist and/or ...
Eligibility Criteria
Inclusion
- 65 year old human adults
- who fill a prescription for at least 5 medications
- community dwelling
- chronic use (3 months or longer) of at least one potentially inappropriate medication (e.g. benzodiazepine, oxybutynin)
Exclusion
- patients with severe mental illness, dementia and epilepsy
- concomitant consumption of any other antipsychotic medication (including lithium, olanzapine, clozapine, quetiapine, risperidone, haloperidol etc.)
- concomitant consumption of any antiepileptic (including carbamazepine, valproate, gabapentin, lamotrigine, topiramate, oxcarbazepine etc.)
- concomitant consumption of a cholinesterase inhibitor or memantine
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01148186
Start Date
June 1 2010
End Date
May 1 2013
Last Update
May 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Le Groupe Jean Coutu Inc.
Longueuil, Quebec, Canada, J4G 1S8